Zacks Research Has Optimistic Outlook of Humana Q3 Earnings

Humana Inc. (NYSE:HUM - Free Report) - Investment analysts at Zacks Research increased their Q3 2026 earnings per share (EPS) estimates for Humana in a report issued on Wednesday, July 2nd. Zacks Research analyst D. Chatterjee now forecasts that the insurance provider will post earnings per share of $2.21 for the quarter, up from their prior forecast of $2.20. The consensus estimate for Humana's current full-year earnings is $16.47 per share. Zacks Research also issued estimates for Humana's Q4 2026 earnings at ($2.91) EPS and Q1 2027 earnings at $7.50 EPS.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.23 EPS.

Several other research firms have also recently commented on HUM. Raymond James Financial raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a research note on Thursday, May 1st. Barclays set a $268.00 target price on Humana and gave the stock an "equal weight" rating in a research report on Thursday, June 12th. Mizuho increased their target price on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Guggenheim began coverage on Humana in a report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price target for the company. Finally, Bank of America reduced their price target on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a report on Tuesday, June 17th. Sixteen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $280.76.

Humana Stock Down 2.1%

NYSE HUM opened at $238.58 on Friday. The stock's 50 day simple moving average is $240.79 and its 200 day simple moving average is $258.69. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91. Humana has a one year low of $212.45 and a one year high of $406.46. The firm has a market cap of $28.79 billion, a PE ratio of 16.87, a price-to-earnings-growth ratio of 1.84 and a beta of 0.44.

Institutional Investors Weigh In On Humana

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of Humana by 8.9% during the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. Dodge & Cox increased its stake in shares of Humana by 5.5% in the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock worth $2,845,830,000 after purchasing an additional 557,175 shares in the last quarter. Pzena Investment Management LLC increased its holdings in Humana by 6.1% in the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock worth $1,013,133,000 after acquiring an additional 219,541 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Humana by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after buying an additional 63,562 shares in the last quarter. Finally, Invesco Ltd. increased its stake in Humana by 29.8% in the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after buying an additional 550,692 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.48%. Humana's payout ratio is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.